Natixis Evolent Health, Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Evolent Health, Inc. stock. As of the latest transaction made, Natixis holds 73,101 shares of EVH stock, worth $926,189. This represents 0.01% of its overall portfolio holdings.

Number of Shares

73,101

Holding current value

$926,189

% of portfolio

0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.41 - $32.97 $1.35 Million - $2.41 Million	73,101 New	73,101 $2.07 Million
Q1 2024 May 13, 2024	BUY	$29.41 - $34.72 $1.19 Million - $1.41 Million	40,492 New	40,492 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$25.0 - $31.4 $378,925 - $475,929	15,157 New	15,157 $412,000
Q1 2023 May 12, 2023	SELL	$26.35 - $35.8 $527,000 - $716,000	-20,000 Reduced 88.45%	2,611 $84,000
Q4 2022 Feb 24, 2023	BUY	$22.21 - $37.41 $222,100 - $374,099	10,000 Added 79.3%	22,611 $634,000
Q4 2022 Feb 13, 2023	BUY	$22.21 - $37.41 $280,090 - $471,777	12,611 New	12,611 $354,000
Q2 2022 Aug 12, 2022	SELL	$25.9 - $32.26 $182,828 - $227,723	-7,059 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$22.14 - $32.3 $3,608 - $5,264	-163 Reduced 2.26%	7,059 $228,000
Q4 2021 Feb 14, 2022	SELL	$25.36 - $34.11 $46,205 - $62,148	-1,822 Reduced 20.15%	7,222 $200,000
Q3 2021 Nov 12, 2021	BUY	$20.93 - $31.0 $189,290 - $280,364	9,044 New	9,044 $280,000
Q3 2020 Nov 12, 2020	SELL	$7.4 - $14.33 $74,532 - $144,331	-10,072 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$4.8 - $9.42 $48,345 - $94,878	10,072 New	10,072 $72,000
Q1 2020 May 14, 2020	SELL	$3.64 - $11.77 $165,390 - $534,793	-45,437 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.49 - $10.68 $13,421 - $22,086	-2,068 Reduced 4.35%	45,437 $413,000
Q3 2019 Nov 13, 2019	SELL	$5.82 - $8.31 $8,392 - $11,983	-1,442 Reduced 2.95%	47,505 $342,000
Q2 2019 Aug 13, 2019	BUY	$7.71 - $14.54 $261,854 - $493,822	33,963 Added 226.66%	48,947 $389,000
Q1 2019 May 15, 2019	BUY	$12.17 - $20.92 $56,456 - $97,047	4,639 Added 44.84%	14,984 $187,000
Q4 2018 Feb 14, 2019	BUY	$17.75 - $27.2 $183,623 - $281,384	10,345 New	10,345 $206,000
Q3 2018 Nov 14, 2018	SELL	$20.1 - $28.75 $339,087 - $485,012	-16,870 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.8 - $23.95 $232,806 - $404,036	16,870 New	16,870 $355,000

Others Institutions Holding EVH

# of Institutions

304

Shares Held

124M

Call Options Held

1.88M

Put Options Held

2.36M

Wellington Management Group LLP Boston, MA

12.6M
Shares

$160 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

10.9M
Shares

$138 Million
0.01% of portfolio
Black Rock Inc. New York, NY

8.69M
Shares

$110 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

8.51M
Shares

$108 Million
3.36% of portfolio
William Blair Investment Management, LLC Chicago, IL

4.94M
Shares

$62.6 Million
0.36% of portfolio

View Full List

About Evolent Health, Inc.

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $1.23B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

More about EVH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account